Koers Health Discovery Corporation Other OTC
Aandelen
HDVY
US42218R1005
Biotechnologie & Medisch Onderzoek
Omzet 2019 | 1,52 mln. 1,42 mln. | Omzet 2020 | 1K 932,74 | Marktkapitalisatie | 18,27 mln. 17,04 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2019 | 1 mln. 933K | Nettowinst (verlies) 2020 | - 0 | EV/omzet 2019 | 6,91 x |
Nettoliquiditeiten 2019 | 2,1 mln. 1,95 mln. | Nettoliquiditeiten 2020 | 705K 658K | EV/omzet 2020 | 17.568 x |
K/w-verhouding 2019 |
12,5
x | K/w-verhouding 2020 |
-22,6
x | Werknemers | - |
Dividendrendement 2019 * |
-
| Dividendrendement 2020 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Hong Zhang
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-04 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Edward Morrison
BRD | Director/Board Member | 51 | 26-04-17 |
Director/Board Member | 49 | 09-05-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-20,55% | 10,81 mld. | |
+47,97% | 3,36 mld. | |
-32,75% | 2,22 mld. | |
-14,15% | 2,16 mld. | |
-26,06% | 1,55 mld. | |
+19,85% | 1,04 mld. | |
-2,62% | 746 mln. | |
-31,67% | 425 mln. | |
-43,88% | 405 mln. |